7
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      An investigation of herpes simplex virus type 1 latency in a novel mouse dorsal root ganglion model suggests a role for ICP34.5 in reactivation.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          After a primary lytic infection at the epithelia, herpes simplex virus type 1 (HSV-1) enters the innervating sensory neurons and translocates to the nucleus, where it establishes a quiescent latent infection. Periodically, the virus can reactivate and the progeny viruses spread back to the epithelium. Here, we introduce an embryonic mouse dorsal root ganglion (DRG) culture system, which can be used to study the mechanisms that control the establishment, maintenance and reactivation from latency. Use of acyclovir is not necessary in our model. We examined different phases of the HSV-1 life cycle in DRG neurons, and showed that WT HSV-1 could establish both lytic and latent form of infection in the cells. After reactivating stimulus, the WT viruses showed all markers of true reactivation. In addition, we showed that deletion of the γ(1)34.5 gene rendered the virus incapable of reactivation, even though the virus was clearly able to replicate and persist in a quiescent form in the DRG neurons.

          Related collections

          Author and article information

          Journal
          J. Gen. Virol.
          The Journal of general virology
          Microbiology Society
          1465-2099
          0022-1317
          Aug 2015
          : 96
          : 8
          Affiliations
          [1 ] Research Center for Biomedicine, Department of Medical Microbiology and Immunology, University of Oulu, Oulu, Finland.
          [2 ] Department of Virology, University of Turku, Turku, Finland.
          [3 ] Department of Anatomy and Cell Biology, Institute of Biomedicine, University of Oulu, Oulu, Finland.
          [4 ] Drug Research Doctoral Programme, University of Turku, Turku, Finland.
          [5 ] Department of Microbiology, NYU School of Medicine, New York, NY, USA.
          Article
          10.1099/vir.0.000138
          25854552
          d43bc00f-2ec0-4b39-8c14-ce1d1054fb95
          History

          Comments

          Comment on this article